资讯
Why do some older adults easily remember the name of a new acquaintance or the location of their keys, while others struggle ...
22 小时on MSN
New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...
Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic ...
11 小时
News-Medical.Net on MSNTargeting ADAM10 may offer hope for retinal disease treatmentNew research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...
VISTA, Calif., June 25, 2025 /PRNewswire/ — In a significant stride toward transforming the future of cancer diagnostics and ...
A new study has revealed that newborn babies and Alzheimer’s patients both have elevated levels of the same protein, p-tau217 ...
Phase Ib trial, ANDECA-HO, assessing the humanised antibody, andecaliximab, in spinal cord injury (SCI) patients at risk of ...
A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...
Riliprubart is an immunoglobulin G4 humanized antibody that is designed to selectively inhibit activated C1s in the classical complement pathway of the innate immune system.
Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果